Search research articles
Contact Us
Filters
Showing results (41-50 of 57) with videos related to
Page
of 6
Sort By:
Journal of the American Academy of Dermatology
|
January 1, 1983
Propionibacterium acnes resistance to antibiotics in acne patients
J J Leyden, K J McGinley, S Cavalieri, et al.
Acta Endocrinologica
|
April 1, 1989
Calcitonin inhibition of growth hormone-releasing hormone-induced GH secretion in normal men
G P Ceda, L Denti, G Ceresini, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism
|
September 16, 2017
Management of tyrosine kinase inhibitors (TKI) side effects in differentiated and medullary thyroid cancer patients
C Resteghini, S Cavalieri, D Galbiati, et al.
Acta Europaea Fertilitatis
|
May 1, 1988
Induction of ovulation for gamete intrafallopian transfer (GIFT) using a gonadotropin-releasing hormone agonist and "pure" FSH: results obtained in 30 normally menstruating women
G B La Sala, M Cantarelli, G Parolari, et al.
Physical Review Letters
|
February 9, 2005
Comment on "electromagnetically induced quantum memory"
B W Shore, D Charalambidis, M Shapiro, et al.
Endocrine
|
April 2, 2021
Late toxicities burden in patients with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib
F Platini, S Cavalieri, S Alfieri, et al.
European Journal of Neurology
|
December 8, 2009
A family with autosomal dominant leukodystrophy linked to 5q23.2-q23.3 without lamin B1 mutations
A Brussino, G Vaula, C Cagnoli, et al.
Journal of Endocrinological Investigation
|
March 23, 2017
The steroid response to human chorionic gonadotropin (hCG) stimulation in men with Klinefelter syndrome does not change using immunoassay or mass spectrometry
L Roli, D Santi, S Belli, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 17, 2019
Adjuvant androgen deprivation therapy for poor-risk, androgen receptor-positive salivary duct carcinoma
W van Boxtel, L D Locati, A C H van Engen-van Grunsven, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 8, 2018
Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer
S Cavalieri, F Perrone, R Miceli, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 57) with videos related to
Sort By:
Page
of 6
Journal of the American Academy of Dermatology
|
January 1, 1983
Propionibacterium acnes resistance to antibiotics in acne patients
J J Leyden, K J McGinley, S Cavalieri, et al.
Acta Endocrinologica
|
April 1, 1989
Calcitonin inhibition of growth hormone-releasing hormone-induced GH secretion in normal men
G P Ceda, L Denti, G Ceresini, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism
|
September 16, 2017
Management of tyrosine kinase inhibitors (TKI) side effects in differentiated and medullary thyroid cancer patients
C Resteghini, S Cavalieri, D Galbiati, et al.
Acta Europaea Fertilitatis
|
May 1, 1988
Induction of ovulation for gamete intrafallopian transfer (GIFT) using a gonadotropin-releasing hormone agonist and "pure" FSH: results obtained in 30 normally menstruating women
G B La Sala, M Cantarelli, G Parolari, et al.
Physical Review Letters
|
February 9, 2005
Comment on "electromagnetically induced quantum memory"
B W Shore, D Charalambidis, M Shapiro, et al.
Endocrine
|
April 2, 2021
Late toxicities burden in patients with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib
F Platini, S Cavalieri, S Alfieri, et al.
European Journal of Neurology
|
December 8, 2009
A family with autosomal dominant leukodystrophy linked to 5q23.2-q23.3 without lamin B1 mutations
A Brussino, G Vaula, C Cagnoli, et al.
Journal of Endocrinological Investigation
|
March 23, 2017
The steroid response to human chorionic gonadotropin (hCG) stimulation in men with Klinefelter syndrome does not change using immunoassay or mass spectrometry
L Roli, D Santi, S Belli, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 17, 2019
Adjuvant androgen deprivation therapy for poor-risk, androgen receptor-positive salivary duct carcinoma
W van Boxtel, L D Locati, A C H van Engen-van Grunsven, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 8, 2018
Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer
S Cavalieri, F Perrone, R Miceli, et al.
Page
of 6